Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis

Aliya Bryce, Sara Davison, Bart J Currie, Johanna M Birrell, Robert W Baird, Asanga Abeyaratne, Sandawana William Majoni, Teana Brewster-O’Brien, Steven Y C Tong

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
47 Downloads (Pure)

Abstract

Hemodialysis is a risk factor for Staphylococcus aureus bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required.
Original languageEnglish
Article numberofae431
Pages (from-to)1-4
Number of pages4
JournalOpen Forum Infectious Diseases
Volume11
Issue number8
DOIs
Publication statusPublished - 1 Aug 2024

Fingerprint

Dive into the research topics of 'Lower Rates of Staphylococcus aureus Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis'. Together they form a unique fingerprint.

Cite this